http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GT-201200341-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2012-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_128ecc0f0e12495a924795560cc61b51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37ee1875a356d9bc457596496846d327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f5eae43b4961f2e34fde9045fef2b96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef195e7d31428c6ae6c6d5dbf495096d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77fc3dfb4b29d41a6b1f91d62c805703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5ec556d94c0334d1d8cbbd39d4d717d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61856a0f4bf14e9f0c58b3503fe21f22
publicationDate 2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GT-201200341-A
titleOfInvention USE OF THE ASSOCIATION OF A SINUSAL CORREINTE IF INHIBITOR AND OF AN ANGIOTENSIN CONVERSION ENZYME INHIBITOR FOR THE TREATMENT OF HEART FAILURE
abstract USE OF THE ASSOCIATION OF A SELECTIVE AND SPECIFIC INHIBITOR OF THE SINUSAL CURRENT IF, MORE PARTICULARLY THE IVABRADINE OR THE N - {[(7S) -3,4-DIMETOXIBICICLO [4.2.0] OCTA-1,3,5-TRIEN- 7-IL] METHYL} -3- (7,8-DIMETOXI-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-IL) -N-METHYL-3-OXO-1-PROPANAMINE AND AN INHIBITING AGENT OF THE ANGIOTENSIN CONVERSION ENZYME FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF HEART FAILURE, MORE PARTICULARLY OF HEART FAILURE WITH SYSTOLIC FUNCTION CONSERVED.
priorityDate 2010-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132999

Total number of triples: 28.